Finance

Mga Listahan
THC:NYSE
Tenet Healthcare Corp
$258.62
+1.83%
(+4.65) 1D
$258.62
0.00% (0.00)
Pagkalipas ng oras ng trabaho
Sarado: Okt 2, 4:00:04 PM GMT-4  ·   USD
Lahat ng simbolo
SimboloPresyoPalitan% ng Pagbabago
Bumubuo ng mga nangungunang insight para sa THC...
Buksan
$255.38
Mataas
$260.99
Mababa
$254.98
Mkt. cap
20.82B
Avg. na dami
777.67K
Dami
574.59K
P/E ratio
9.97
Mataas nang 52-wk
$283.05
Mababa nang 52-wk
$157.58
EPS
$25.93
Beta
1.20
Mga natitirang share
80.52M
Bilang ng mga empleyado
88K
Buksan
$255.38
Mataas
$260.99
Mababa
$254.98
Mkt. cap
20.82B
Avg. na dami
777.67K
Dami
574.59K
P/E ratio
9.97
Mataas nang 52-wk
$283.05
Mababa nang 52-wk
$157.58
EPS
$25.93
Beta
1.20
Mga natitirang share
80.52M
Bilang ng mga empleyado
88K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Profile
Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International, the company operates around 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients. Since its founding in 1969, Tenet has expanded significantly. Among other major acquisitions and formations, Tenet founded Conifer Health Solutions in 2008, MedPost Urgent Care in 2014, and in 2013 acquired Vanguard Health Systems, Inc., an investor-owned hospital company whose operations complemented Tenet's existing business. The acquisition created the third-largest investor-owned hospital company in the United States in terms of revenue and the third-largest in number of hospitals owned. In 2015, Tenet acquired USPI, which created the largest operator of outpatient surgery centers in the U.S. In 2021, the company ranked 167th in the Fortune 500. Wikipedia
Tungkol sa Tenet Healthcare Corp
CEOSaum Sutaria
Mga Empleyado88.5K
Itinatag1969
HeadquartersDallas, Texas, Estados Unidos
SektorHealth care provider
Mga rating ng analyst
Batay sa 18 (na) analyst na nagbigay ng mga rating ng stock sa THC sa nakalipas na 3 buwan
Strong buy
Pagbili
16
Pag-hold
2
Pagbebenta
0
12 buwang forecas
Batay sa 18 (na) analyst sa Wall Street na nag-aalok ng mga target na presyo sa loob ng 12 buwan para sa THC sa nakalipas na 3 buwan.
Pinakamataas
Kasalukuyan $258.62
$315.00 (+21.80%)
Average
$283.41 (+9.59%)
Pinakamababa
$245.00 (-5.27%)
Analyst
Rekomendasyon
Aksyon
Target na presyo
Inaasahan
Petsa
Andrew Cooper
Raymond James
Buy
Reiterated
$285.00
+10.2%
09/28/2026
Sean Dodge
BMO Capital
Hold
Initiated
$265.00
+2.5%
09/22/2026
Whit Mayo
Leerink Partners
Buy
Reiterated
-
-
09/17/2026
Craig Hettenbach
Morgan Stanley
Buy
Maintained
$274.00
+5.9%
09/14/2026
Benjamin Rossi
J.P. Morgan
Buy
Maintained
$315.00
+21.8%
09/01/2026
A.J. Rice
UBS
Buy
Maintained
$308.00
+19.1%
08/25/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
$290.00
+12.1%
08/10/2026
Kevin Fischbeck
Bank of America Securities
Buy
Reiterated
$295.00
+14.1%
08/10/2026
Stephen Baxter
Wells Fargo
Buy
Reiterated
$281.00
+8.7%
07/31/2026
Scott Fidel
Goldman Sachs
Buy
Reiterated
$305.00
+17.9%
07/29/2026
Jason Cassorla
Guggenheim
Buy
Maintained
$283.00
+9.4%
07/27/2026
Michael Ha
Robert W. Baird
Hold
Maintained
$280.00
+8.3%
07/28/2026
Unknown Analyst
Stephens
Buy
Maintained
$285.00
+10.2%
07/27/2026
Raj Kumar CFA
Stephens
Buy
Maintained
$285.00
+10.2%
07/27/2026
David S Macdonald
Truist Financial
Buy
Reiterated
$290.00
+12.1%
07/28/2026
Ben Hendrix
RBC Capital
Buy
Reiterated
$283.00
+9.4%
07/26/2026
Ryan Langston
TD Cowen
Buy
Reiterated
$263.00
+1.7%
07/27/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
$245.00
-5.3%
07/23/2026
Andrew Mok CFA
Barclays
Buy
Maintained
$271.00
+4.8%
07/24/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
$225.00
-13%
05/01/2026
Huling ulat
Hul 24, 2026
Fiscal period
Q2 2026
EPS / Pagtataya (USD)
$6.12 / $4.26
+43.54%lumampas
Kita / Pagtataya (USD)
5.63B / 5.44B
+3.53%lumampas
Earnings call para sa Fiscal Q2 2026
Hinihintay ang earnings call
Sa isang sulyap
Mga insight mula sa mga pinakabagong balita at ulat
Mga nakaraang ulatLahat ng value sa USD
Loading Previous Earnings...
Kita
Net na kita
Lahat ng value sa USD
Set 2025
Dis 2025
Mar 2026
Hun 2026
Kita
5.29B
5.53B
5.37B
5.63B
Gastusin sa mga naibentang produkto
3.14B
3.23B
3.14B
3.22B
Halaga ng kita
3.14B
3.23B
3.14B
3.22B
Mga gastos sa pananaliksik at pag-develop
-
-
-
-
Kabuuang gastos sa pananaliksik at pag-develop
-
-
-
-
Mga gastos sa pagbebenta, pangkalahatan, at admin
102.00M
410.00M
102.00M
104.00M
Gastos sa pagpapatakbo
1.34B
1.33B
1.27B
1.39B
Kabuuang gastos sa pagpapatakbo
4.47B
4.56B
4.40B
4.61B
Kita sa pagpapatakbo
815.00M
965.00M
963.00M
1.02B
Iba pang hindi kita sa pagpapatakbo
31.00M
39.00M
43.00M
45.00M
EBT na may mga hindi karaniwang item
712.00M
681.00M
1.13B
1.34B
EBT na hindi kasama ang mga hindi karaniwang item
704.00M
882.00M
852.00M
928.00M
Gastos sa buwis sa kita
133.00M
37.00M
226.00M
295.00M
Epektibong rate ng buwis
18.68%
5.43%
19.96%
22.01%
Iba pang gastos sa pagpapatakbo
1.02B
687.00M
937.00M
1.07B
Net na kita
342.00M
371.00M
702.00M
826.00M
Margin ng kabuuang kita
6.47%
6.71%
13.08%
14.68%
Kita bawat share
3.70
4.70
4.82
6.12
Kita sa interes at investment
-
-
-
-
Gastos sa interes
-206.00M
-205.00M
-205.00M
-204.00M
Mga net na gastos sa interes
-206.00M
-205.00M
-205.00M
-204.00M
Mga singil sa depreciation at amortization
218.00M
231.00M
229.00M
215.00M
EBITDA
1.03B
1.20B
1.19B
1.24B
Kita o pagkalugi mula sa pagbebenta ng mga asset
-20.00M
5.00M
-1.00M
-33.00M
Mga transaksyon ng insider
Kinukuha ang data ng mga insider na transaksyon mula sa mga third-party na source. Matuto pa
Insider
Posisyon
Uri
Petsa
Mga Share
Halaga
Page 1
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa
Mga app ng Google